TRPM7, the cytoskeleton and neuronal death

Channels

Volumn 7, Issue 1, 2013, Pages

  Asrar, Suhail ^a   Aarts, Michelle ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anoxia; Calcium; Cofilin; Cytoskeleton; Ischemia; Kinase; Neuron; OGD; Stroke; TRPM7

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ACID SENSING ION CHANNEL; AMPA RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; DIZOCILPINE; DOCEBENONE; EXCITATORY AMINO ACID TRANSPORTER; GAP JUNCTION PROTEIN; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NAFAMSTAT MESILATE; NIMODIPINE; NORDIHYDROGUAIARETIC ACID; NS 8593; POTASSIUM CHANNEL AFFECTING AGENT; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; UNCLASSIFIED DRUG; CALCIUM; COFILIN; PHOSPHOTRANSFERASE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM7 PROTEIN, HUMAN;

BRAIN ISCHEMIA; BRAIN NERVE CELL; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL HYPOXIA; CYTOSKELETON; EXCITOTOXICITY; HUMAN; NERVE CELL NECROSIS; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; ANIMAL; ANOXIA; CELL DEATH; CEREBROVASCULAR ACCIDENT; CYTOLOGY; GENETICS; ISCHEMIA; METABOLISM; NERVE CELL; OGD; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; TRPM7;

ANOXIA; CALCIUM; COFILIN; CYTOSKELETON; ISCHEMIA; KINASE; NEURON; OGD; STROKE; TRPM7;

ANIMALS; CELL DEATH; CYTOSKELETON; HUMANS; NEURONS; SIGNAL TRANSDUCTION; STROKE; TRPM CATION CHANNELS;

EID: 84872288986     PISSN: 19336950     EISSN: 19336969     Source Type: Journal    
DOI: 10.4161/chan.22824     Document Type: Review

References (145)

1. Kroemer G, El-Deiry WS, Golstein P, Peter ME, Vaux D, Vandenabeele P, et al.; Nomenclature Committee on Cell Death. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2005; 12(Suppl 2):1463-7; PMID:16247491; http://dx.doi.org/10.1038/sj.cdd. 4401724.
2. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, et al.; Nomenclature Committee on Cell Death 2009. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009; 16:3-11; PMID:18846107; http://dx.doi.org/10.1038/cdd.2008. 150.
3. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19:107-20; PMID:21760595; http://dx.doi.org/10.1038/cdd.2011.96.
4. Cairns NJ, Lee VM-Y, Trojanowski JQ. The cytoskeleton in neurodegenerative diseases. J Pathol 2004; 204:438-49; PMID:15495240; http://dx.doi.org/10.1002/path.1650.
5. Janmey PA. The cytoskeleton and cell signaling: component localization and mechanical coupling. Physiol Rev 1998; 78:763-81; PMID:9674694.
6. Carpenter CL. Actin cytoskeleton and cell signaling. Crit Care Med 2000; 28(Suppl):N94-9; PMID:10807321; http://dx.doi.org/10.1097/00003246-200004001- 00011.
7. Sheng M, Pak DT. Ligand-gated ion channel interactions with cytoskeletal and signaling proteins. Annu Rev Physiol 2000; 62:755-78; PMID:10845110; http://dx.doi.org/10.1146/annurev.physiol.62.1.755.
8. Dillon C, Goda Y. The actin cytoskeleton: integrating form and function at the synapse. Annu Rev Neurosci 2005; 28:25-55; PMID:16029114; http://dx.doi.org/10.1146/annurev.neuro.28.061604.135757.
9. Mazzochi C, Benos DJ, Smith PR. Interaction of epithelial ion channels with the actin-based cytoskeleton. Am J Physiol Renal Physiol 2006; 291:F1113-22; PMID:16926444; http://dx.doi.org/10.1152/ajprenal.00195.2006.
10. Fletcher DA, Mullins RD. Cell mechanics and the cytoskeleton. Nature 2010; 463:485-92; PMID:20110992; http://dx.doi.org/10.1038/nature08908.
11. Dominguez R. Structural insights into de novo actin polymerization. Curr Opin Struct Biol 2010; 20:217-25; PMID:20096561; http://dx.doi.org/10.1016/j. sbi.2009.12.012.
12. Penzes P, Rafalovich I. Regulation of the actin cytoskeleton in dendritic spines. Adv Exp Med Biol 2012; 970:81-95; PMID:22351052; http://dx.doi.org/10. 1007/978-3-7091-0932-8-4.
13. Laster SM, Mackenzie JM Jr. Bleb formation and F-actin distribution during mitosis and tumor necrosis factor-induced apoptosis. Microsc Res Tech 1996; 34:272-80; PMID:8743415; http://dx.doi.org/10.1002/(SICI)1097- 0029(19960615)34:3〈272::AIDJEMT10〉3.0.CO;2-J.
14. Levee MG, Dabrowska MI, Lelli JL Jr., Hinshaw DB. Actin polymerization and depolymerization during apoptosis in HL-60 cells. Am J Physiol 1996; 271:C1981-92; PMID:8997201.
15. van Engeland M, Kuijpers HJ, Ramaekers FC, Reutelingsperger CP, Schutte B. Plasma membrane alterations and cytoskeletal changes in apoptosis. Exp Cell Res 1997; 235:421-30; PMID:9299167; http://dx.doi.org/10.1006/excr.1997.3738.
16. Gourlay CW, Carpp LN, Timpson P, Winder SJ, Ayscough KR. A role for the actin cytoskeleton in cell death and aging in yeast. J Cell Biol 2004; 164:803-9; PMID:15024029; http://dx.doi.org/10.1083/jcb.200310148.
17. Kavanagh E, Vlachos P, Emourgeon V, Rodhe J, Joseph B. p57(KIP2) control of actin cytoskeleton dynamics is responsible for its mitochondrial pro-apoptotic effect. Cell Death Dis 2012; 3:e311; PMID:22592318; http://dx.doi.org/10.1038/cddis.2012.51.
18. Pawlik A, Szczepanski MA, Klimaszewska A, Gackowska L, Zuryn A, Grzanka A. Phenethyl isothiocyanate-induced cytoskeletal changes and cell death in lung cancer cells. Food Chem Toxicol 2012; 50:3577-94; PMID:22847136; http://dx.doi.org/10.1016/j.fct.2012.07.043.
19. van Haelst C, Rothstein TL. Cytochalasin stimulates phosphoinositide metabolism in murine B lymphocytes. J Immunol 1988; 140:1256-8; PMID:2830337.
20. Rosales C, Brown EJ. Signal transduction by neutrophil immunoglobulin G Fc receptors. Dissociation of intracytoplasmic calcium concentration rise from inositol 1,4,5-trisphosphate. J Biol Chem 1992; 267:5265-71; PMID:1531982.
21. Lange K, Brandt U. Calcium storage and release properties of F-actin: evidence for the involvement of F-actin in cellular calcium signaling. FEBS Lett 1996; 395:137-42; PMID:8898081; http://dx.doi.org/10.1016/0014-5793(96)01025-3.
22. Schlaepfer WW, Bunge RP. Effects of calcium ion concentration on the degeneration of amputated axons in tissue culture. J Cell Biol 1973; 59:456-70; PMID:4805010; http://dx.doi.org/10.1083/jcb.59.2.456.
23. Schanne FA, Kane AB, Young EE, Farber JL. Calcium dependence of toxic cell death: a final common pathway. Science 1979; 206:700-2; PMID:386513; http://dx.doi.org/10.1126/science.386513.
24. Choi DW. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 1985; 58:293-7; PMID:2413399; http://dx.doi.org/10. 1016/0304-3940(85)90069-2.
25. Beal MF. Mechanisms of excitotoxicity in neurologic diseases. FASEB J 1992; 6:3338-44; PMID:1464368.
26. Hazell AS. Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies. Neurochem Int 2007; 50:941-53; PMID:17576023; http://dx.doi.org/10.1016/j.neuint.2007.04.026.
27. Dong XX, Wang Y, Qin ZH. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin 2009; 30:379-87; PMID:19343058; http://dx.doi.org/10.1038/aps.2009.24.
28. Szydlowska K, Tymianski M. Calcium, ischemia and excitotoxicity. Cell Calcium 2010; 47:122-9; PMID:20167368; http://dx.doi.org/10.1016/j.ceca.2010.01. 003.
29. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969; 164:719-21; PMID:5778021; http://dx.doi.org/10.1126/science.164.3880.719.
30. Simon RP, Griffiths T, Evans MC, Swan JH, Meldrum BS. Calcium overload in selectively vulnerable neurons of the hippocampus during and after ischemia: an electron microscopy study in the rat. J Cereb Blood Flow Metab 1984; 4:350-61; PMID:6470053; http://dx.doi.org/10.1038/jcbfm.1984.52.
31. Goldberg MP, Weiss JH, Pham PC, Choi DW. N-methyl-D-aspartate receptors mediate hypoxic neuronal injury in cortical culture. J Pharmacol Exp Ther 1987; 243:784-91; PMID:2890761.
32. Choi DW, Maulucci-Gedde M, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture. J Neurosci 1987; 7:357-68; PMID:2880937.
33. Sattler R, Charlton MP, Hafner M, Tymianski M. Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity. J Neurochem 1998; 71:2349-64; PMID:9832133; http://dx.doi.org/10.1046/j.1471-4159. 1998.71062349.x.
34. Rothman S. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J Neurosci 1984; 4:1884-91; PMID:6737044.
35. Choi DW. Ionic dependence of glutamate neurotoxicity. J Neurosci 1987; 7:369-79; PMID:2880938.
36. Buchan AM, Li H, Cho S, Pulsinelli WA. Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats. Neurosci Lett 1991; 132:255-8; PMID:1664505; http://dx.doi.org/10.1016/0304-3940(91)90314-J.
37. Sheardown MJ, Suzdak PD, Nordholm L. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. Eur J Pharmacol 1993; 236:347-53; PMID:7689464; http://dx.doi.org/10.1016/ 0014-2999(93)90470-3.
38. Liu S, Lau L, Wei J, Zhu D, Zou S, Sun H-S, et al. Expression of Ca(2+)-permeable AMPA receptor channels primes cell death in transient forebrain ischemia. Neuron 2004; 43:43-55; PMID:15233916; http://dx.doi.org/10.1016/j. neuron.2004.06.017.
39. Besancon E, Guo S, Lok J, Tymianski M, Lo EH. Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol Sci 2008; 29:268-75; PMID:18384889; http://dx.doi.org/10.1016/j.tips.2008.02.003.
40. Li MH, Inoue K, Si HF, Xiong ZG. Calciumpermeable ion channels involved in glutamate receptorindependent ischemic brain injury. Acta Pharmacol Sin 2011; 32:734-40; PMID:21552295; http://dx.doi.org/10.1038/aps.2011.47.
41. Aarts M, Iihara K, Wei W-L, Xiong Z-G, Arundine M, Cerwinski W, et al. A key role for TRPM7 channels in anoxic neuronal death. Cell 2003; 115:863-77; PMID:14697204; http://dx.doi.org/10.1016/S0092-8674(03)01017-1.
42. Wei W-L, Sun H-S, Olah ME, Sun X, Czerwinska E, Czerwinski W, et al. TRPM7 channels in hippocampal neurons detect levels of extracellular divalent cations. Proc Natl Acad Sci USA 2007; 104:16323-8; PMID:17913893; http://dx.doi.org/10.1073/pnas.0701149104.
43. Sun H-S, Jackson MF, Martin LJ, Jansen K, Teves L, Cui H, et al. Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia. Nat Neurosci 2009; 12:1300-7; PMID:19734892; http://dx.doi.org/10.1038/nn.2395.
44. Nuñez-Villena F, Becerra A, Echeverría C, Briceño N, Porras O, Armisén R, et al. Increased expression of the transient receptor potential melastatin 7 channel is critically involved in lipopolysaccharide-induced reactive oxygen species-mediated neuronal death. Antioxid Redox Signal 2011; 15:2425-38; PMID:21539414; http://dx.doi.org/10. 1089/ars.2010.3825.
45. Coombes E, Jiang J, Chu X-P, Inoue K, Seeds J, Branigan D, et al. Pathophysiologically relevant levels of hydrogen peroxide induce glutamate-independent neurodegeneration that involves activation of transient receptor potential melastatin 7 channels. Antioxid Redox Signal 2011; 14:1815-27; PMID:20812867; http://dx.doi.org/10.1089/ars.2010.3549.
46. Inoue K, Branigan D, Xiong Z-G. Zinc-induced neurotoxicity mediated by transient receptor potential melastatin 7 channels. J Biol Chem 2010; 285:7430-9; PMID:20048154; http://dx.doi.org/10.1074/jbc.M109.040485.
47. Zhang J, Zhao F, Zhao Y, Wang J, Pei L, Sun N, et al. Hypoxia induces an increase in intracellular magnesium via transient receptor potential melastatin 7 (TRPM7) channels in rat hippocampal neurons in vitro. J Biol Chem 2011; 286:20194-207; PMID:21487014; http://dx.doi.org/10.1074/jbc.M110.148494.
48. Rapport RL. Nerve Endings: The Discovery Of The Synapse. W.W. Norton; 2005.
49. Lynch MA. Long-term potentiation and memory. Physiol Rev 2004; 84:87-136; PMID:14715912; http://dx.doi.org/10.1152/physrev.00014.2003.
50. Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron 2004; 44:5-21; PMID:15450156; http://dx.doi.org/10.1016/j.neuron.2004.09.012.
51. Collingridge GL, Peineau S, Howland JG, Wang YT. Long-term depression in the CNS. Nat Rev Neurosci 2010; 11:459-73; PMID:20559335; http://dx.doi.org/10. 1038/nrn2867.
52. Amara SG, Fontana ACK. Excitatory amino acid transporters: keeping up with glutamate. Neurochem Int 2002; 41:313-8; PMID:12176072; http://dx.doi.org/10.1016/S0197-0186(02)00018-9.
53. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996; 16:675-86; PMID:8785064; http://dx.doi.org/10.1016/S0896-6273(00)80086-0.
54. Davis SM, Albers GW, Diener HC, Lees KR, Norris J. Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed. Lancet 1997; 349:32; PMID:8999265; http://dx.doi.org/10.1016/S0140-6736(05)62166-6.
55. Morris GF, Bullock R, Marshall SB, Marmarou A, Maas A, Marshall LF; The Selfotel Investigators. Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. J Neurosurg 1999; 91:737-43; PMID:10541229; http://dx.doi.org/10.3171/jns.1999.91.5.0737.
56. Lees KR, Asplund K, Carolei A, Davis SM, Diener HC, Kaste M, et al.; GAIN International Investigators. Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. Lancet 2000; 355:1949-54; PMID:10859040; http://dx.doi.org/10.1016/S0140- 6736(00)02326-6.
57. Sacco RL, DeRosa JT, Haley EC Jr., Levin B, Ordronneau P, Phillips SJ, et al.; Glycine Antagonist in Neuroprotection Americas Investigators. Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA 2001; 285:1719-28; PMID:11277826; http://dx.doi.org/10.1001/jama.285.13.1719.
58. Xiong Z-G, Zhu X-M, Chu X-P, Minami M, Hey J, Wei W-L, et al. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell 2004; 118:687-98; PMID:15369669; http://dx.doi.org/10.1016/j. cell.2004.08.026.
59. Xiong Z-G, Chu X-P, Simon RP. Acid sensing ion channels - novel therapeutic targets for ischemic brain injury. Front Biosci 2007; 12:1376-86; PMID:17127388; http://dx.doi.org/10.2741/2154.
60. Li M, Kratzer E, Inoue K, Simon RP, Xiong Z-G. Developmental change in the electrophysiological and pharmacological properties of acid-sensing ion channels in CNS neurons. J Physiol 2010; 588:3883-900; PMID:20724366; http://dx.doi.org/10.1113/jphysiol.2010.192922.
61. Oguro K, Jover T, Tanaka H, Lin Y, Kojima T, Oguro N, et al. Global ischemia-induced increases in the gap junctional proteins connexin 32 (Cx32) and Cx36 in hippocampus and enhanced vulnerability of Cx32 knock-out mice. J Neurosci 2001; 21:7534-42; PMID:11567043.
62. Contreras JE, Sánchez HA, Véliz LP, Bukauskas FF, Bennett MVL, Sáez JC. Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Res Brain Res Rev 2004; 47:290-303; PMID:15572178; http://dx.doi.org/10.1016/j. brainresrev.2004.08.002.
63. Thompson RJ, Zhou N, MacVicar BA. Ischemia opens neuronal gap junction hemichannels. Science 2006; 312:924-7; PMID:16690868; http://dx.doi.org/10.1126/ science.1126241.
64. Bargiotas P, Krenz A, Hormuzdi SG, Ridder DA, Herb A, Barakat W, et al. Pannexins in ischemia-induced neurodegeneration. Proc Natl Acad Sci USA 2011; 108:20772-7; PMID:22147915; http://dx.doi.org/10.1073/pnas.1018262108.
65. Hara Y, Wakamori M, Ishii M, Maeno E, Nishida M, Yoshida T, et al. LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol Cell 2002; 9:163-73; PMID:11804595; http://dx.doi.org/10.1016/S1097-2765(01)00438-5.
66. Kaneko S, Kawakami S, Hara Y, Wakamori M, Itoh E, Minami T, et al. A critical role of TRPM2 in neuronal cell death by hydrogen peroxide. J Pharmacol Sci 2006; 101:66-76; PMID:16651700; http://dx.doi.org/10.1254/jphs.FP0060128.
67. Verma S, Quillinan N, Yang Y-F, Nakayama S, Cheng J, Kelley MH, et al. TRPM2 channel activation following in vitro ischemia contributes to male hippocampal cell death. Neurosci Lett 2012; 530:41-6; PMID:23041043; http://dx.doi.org/10.1016/j.neulet.2012.09.044.
68. Montell C, Birnbaumer L, Flockerzi V. The TRP channels, a remarkably functional family. Cell 2002; 108:595-8; PMID:11893331; http://dx.doi.org/10. 1016/S0092-8674(02)00670-0.
69. Scharenberg AM. TRPM2 and TRPM7: channel/enzyme fusions to generate novel intracellular sensors. Pflugers Arch 2005; 451:220-7; PMID:16001276; http://dx.doi.org/10.1007/s00424-005-1444-0.
70. Montell C. The TRP superfamily of cation channels. Sci STKE 2005; 2005:re3; PMID:15728426; http://dx.doi.org/10.1126/stke.2722005re3.
71. Miller BA, Zhang W. TRP channels as mediators of oxidative stress. Adv Exp Med Biol 2011; 704:531-44; PMID:21290315; http://dx.doi.org/10.1007/978-94- 007-0265-3-29.
72. Pan Z, Yang H, Reinach PS. Transient receptor potential (TRP) gene superfamily encoding cation channels. Hum Genomics 2011; 5:108-16; PMID:21296744.
73. Nilius B, Owsianik G. The transient receptor potential family of ion channels. Genome Biol 2011; 12:218; PMID:21401968; http://dx.doi.org/10.1186/gb- 2011-12-3-218.
74. Bae CY, Sun HS. TRPM7 in cerebral ischemia and potential target for drug development in stroke. Acta Pharmacol Sin 2011; 32:725-33; PMID:21552293; http://dx.doi.org/10.1038/aps.2011.60.
75. Gaudet R. A primer on ankyrin repeat function in TRP channels and beyond. Mol Biosyst 2008; 4:372-9; PMID:18414734; http://dx.doi.org/10.1039/b801481g.
76. Montell C. Mg2+ homeostasis: the Mg2+nificent TRPM chanzymes. Curr Biol 2003; 13:R799-801; PMID:14561419; http://dx.doi.org/10.1016/j.cub.2003.09.048.
77. Runnels LW, Yue L, Clapham DE. TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 2001; 291:1043-7; PMID:11161216; http://dx.doi.org/10.1126/science.1058519.
78. Riazanova LV, Pavur KS, Petrov AN, Dorovkov MV, Riazanov AG. Novel type of signaling molecules: protein kinases covalently linked to ion channels. Mol Biol (Mosk) 2001; 35:321-32; PMID:11357414.
79. Nadler MJ, Hermosura MC, Inabe K, Perraud AL, Zhu Q, Stokes AJ, et al. LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature 2001; 411:590-5; PMID:11385574; http://dx.doi.org/10.1038/ 35079092.
80. Hanano T, Hara Y, Shi J, Morita H, Umebayashi C, Mori E, et al. Involvement of TRPM7 in cell growth as a spontaneously activated Ca2+ entry pathway in human retinoblastoma cells. J Pharmacol Sci 2004; 95:403-19; PMID:15286426; http://dx.doi.org/10.1254/jphs.FP0040273.
81. Jiang J, Li M-H, Inoue K, Chu X-P, Seeds J, Xiong Z-G. Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation. Cancer Res 2007; 67:10929-38; PMID:18006838; http://dx.doi.org/10.1158/0008-5472.CAN-07-1121.
82. Kim BJ, Park EJ, Lee JH, Jeon J-H, Kim SJ, So I. Suppression of transient receptor potential melastatin 7 channel induces cell death in gastric cancer. Cancer Sci 2008; 99:2502-9; PMID:19032368; http://dx.doi.org/10.1111/j.1349- 7006.2008.00982.x.
83. Kim BJ, Kim S-Y, Lee S, Jeon J-H, Matsui H, Kwon YK, et al. The role of transient receptor potential channel blockers in human gastric cancer cell viability. Can J Physiol Pharmacol 2012; 90:175-86; PMID:22308955; http://dx.doi.org/10.1139/y11-114.
84. Monteilh-Zoller MK, Hermosura MC, Nadler MJS, Scharenberg AM, Penner R, Fleig A. TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. J Gen Physiol 2003; 121:49-60; PMID:12508053; http://dx.doi.org/10. 1085/jgp.20028740.
85. Hermosura MC, Monteilh-Zoller MK, Scharenberg AM, Penner R, Fleig A. Dissociation of the store-operated calcium current I(CRAC) and the Mg-nucleotide-regulated metal ion current MagNuM. J Physiol 2002; 539:445-58; PMID:11882677; http://dx.doi.org/10.1113/jphysiol.2001.013361.
86. Murakami M, Xu F, Miyoshi I, Sato E, Ono K, Iijima T. Identification and characterization of the murine TRPM4 channel. Biochem Biophys Res Commun 2003; 307:522-8; PMID:12893253; http://dx.doi.org/10.1016/S0006-291X(03)01186-0.
87. Zhang W, Chu X, Tong Q, Cheung JY, Conrad K, Masker K, et al. A novel TRPM2 isoform inhibits calcium influx and susceptibility to cell death. J Biol Chem 2003; 278:16222-9; PMID:12594222; http://dx.doi.org/10.1074/jbc.M300298200.
88. Krapivinsky G, Mochida S, Krapivinsky L, Cibulsky SM, Clapham DE. The TRPM7 ion channel functions in cholinergic synaptic vesicles and affects transmitter release. Neuron 2006; 52:485-96; PMID:17088214; http://dx.doi.org/ 10.1016/j.neuron.2006.09.033.
89. Brauchi S, Krapivinsky G, Krapivinsky L, Clapham DE. TRPM7 facilitates cholinergic vesicle fusion with the plasma membrane. Proc Natl Acad Sci USA 2008; 105:8304-8; PMID:18539771; http://dx.doi.org/10.1073/pnas.0800881105.
90. Ilardi JM, Mochida S, Sheng ZH. Snapin: a SNARE-associated protein implicated in synaptic transmission. Nat Neurosci 1999; 2:119-24; PMID:10195194; http://dx.doi.org/10.1038/5673.
91. Rohács T, Lopes CMB, Michailidis I, Logothetis DE. PI(4,5)P2 regulates the activation and desensitization of TRPM8 channels through the TRP domain. Nat Neurosci 2005; 8:626-34; PMID:15852009; http://dx.doi.org/10.1038/ nn1451.
92. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science 2002; 298:1912-34; PMID:12471243; http://dx.doi.org/10.1126/science.1075762.
93. Drennan D, Ryazanov AG. Alpha-kinases: analysis of the family and comparison with conventional protein kinases. Prog Biophys Mol Biol 2004; 85:1-32; PMID:15050379; http://dx.doi.org/10.1016/S0079-6107(03)00060-9.
94. Futey LM, Medley QG, Côté GP, Egelhoff TT. Structural analysis of myosin heavy chain kinase A from Dictyostelium. Evidence for a highly divergent protein kinase domain, an amino-terminal coiled-coil domain, and a domain homologous to the beta-subunit of heterotrimeric G proteins. J Biol Chem 1995; 270:523-9; PMID:7822274.
95. Côté GP, Luo X, Murphy MB, Egelhoff TT. Mapping of the novel protein kinase catalytic domain of Dictyostelium myosin II heavy chain kinase A. J Biol Chem 1997; 272:6846-9; PMID:9054368; http://dx.doi.org/10.1074/jbc. 272.11.6846.
96. Ryazanov AG, Ward MD, Mendola CE, Pavur KS, Dorovkov MV, Wiedmann M, et al. Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase. Proc Natl Acad Sci USA 1997; 94:4884-9; PMID:9144159; http://dx.doi.org/10.1073/pnas.94.10.4884.
97. Ryazanov AG, Pavur KS, Dorovkov MV. Alpha-kinases: a new class of protein kinases with a novel catalytic domain. Curr Biol 1999; 9:R43-5; PMID:10021370; http://dx.doi.org/10.1016/S0960-9822(99)80006-2.
98. Pinna LA, Ruzzene M. How do protein kinases recognize their substrates? Biochim Biophys Acta 1996; 1314:191-225; PMID:8982275; http://dx.doi.org/10. 1016/S0167-4889(96)00083-3.
99. Middelbeek J, Clark K, Venselaar H, Huynen MA, van Leeuwen FN. The alpha-kinase family: an exceptional branch on the protein kinase tree. Cell Mol Life Sci 2010; 67:875-90; PMID:20012461; http://dx.doi.org/10.1007/s00018-009- 0215-z.
100. Runnels LW, Yue L, Clapham DE. The TRPM7 channel is inactivated by PIP(2) hydrolysis. Nat Cell Biol 2002; 4:329-36; PMID:11941371.
101. Clark K, Langeslag M, van Leeuwen B, Ran L, Ryazanov AG, Figdor CG, et al. TRPM7, a novel regulator of actomyosin contractility and cell adhesion. EMBO J 2006; 25:290-301; PMID:16407977; http://dx.doi.org/10.1038/sj.emboj.7600931.
102. Clark K, Middelbeek J, Lasonder E, Dulyaninova NG, Morrice NA, Ryazanov AG, et al. TRPM7 regulates myosin IIA filament stability and protein localization by heavy chain phosphorylation. J Mol Biol 2008; 378:790-803; PMID:18394644; http://dx.doi.org/10.1016/j.jmb.2008.02.057.
103. Dorovkov MV, Ryazanov AG. Phosphorylation of annexin I by TRPM7 channel-kinase. J Biol Chem 2004; 279:50643-6; PMID:15485879; http://dx.doi.org/10.1074/jbc.C400441200.
104. Perraud A-L, Zhao X, Ryazanov AG, Schmitz C. The channel-kinase TRPM7 regulates phosphorylation of the translational factor eEF2 via eEF2-k. Cell Signal 2011; 23:586-93; PMID:21112387; http://dx.doi.org/10.1016/j.cellsig.2010. 11.011.
105. Schmitz C, Perraud A-L, Johnson CO, Inabe K, Smith MK, Penner R, et al. Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell 2003; 114:191-200; PMID:12887921; http://dx.doi.org/10.1016/S0092-8674(03)00556-7.
106. Ryazanova LV, Dorovkov MV, Ansari A, Ryazanov AG. Characterization of the protein kinase activity of TRPM7/ChaK1, a protein kinase fused to the transient receptor potential ion channel. J Biol Chem 2004; 279:3708-16; PMID:14594813; http://dx.doi.org/10.1074/jbc.M308820200.
107. Matsushita M, Kozak JA, Shimizu Y, McLachlin DT, Yamaguchi H, Wei F-Y, et al. Channel function is dissociated from the intrinsic kinase activity and autophosphorylation of TRPM7/ChaK1. J Biol Chem 2005; 280:20793-803; PMID:15781465; http://dx.doi.org/10.1074/jbc.M413671200.
108. Goldberg MP, Choi DW. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci 1993; 13:3510-24; PMID:8101871.
109. Aarts MM, Tymianski M. TRPM7 and ischemic CNS injury. Neuroscientist 2005; 11:116-23; PMID:15746380; http://dx.doi.org/10.1177/1073858404272966.
110. Aarts MM, Tymianski M. TRPMs and neuronal cell death. Pflugers Arch 2005; 451:243-9; PMID:16044308; http://dx.doi.org/10.1007/s00424-005-1439-x.
111. Kolman MF, Futey LM, Egelhoff TT. Dictyostelium myosin heavy chain kinase A regulates myosin localization during growth and development. J Cell Biol 1996; 132:101-9; PMID:8567716; http://dx.doi.org/10.1083/jcb.132.1.101.
112. Rico M, Egelhoff TT. Myosin heavy chain kinase B participates in the regulation of myosin assembly into the cytoskeleton. J Cell Biochem 2003; 88:521-32; PMID:12532328; http://dx.doi.org/10.1002/jcb.10361.
113. Heid PJ, Wessels D, Daniels KJ, Gibson DP, Zhang H, Voss E, et al. The role of myosin heavy chain phosphorylation in Dictyostelium motility, chemotaxis and F-actin localization. J Cell Sci 2004; 117:4819-35; PMID:15340009; http://dx.doi.org/10.1242/jcs.01358.
114. Murphy DA, Courtneidge SA. The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol 2011; 12:413-26; PMID:21697900; http://dx.doi.org/10.1038/nrm3141.
115. Clark K, Middelbeek J, Morrice NA, Figdor CG, Lasonder E, van Leeuwen FN. Massive autophosphorylation of the Ser/Thr-rich domain controls protein kinase activity of TRPM6 and TRPM7. PLoS ONE 2008; 3:e1876; PMID:18365021; http://dx.doi.org/10.1371/journal.pone.0001876.
116. Su L-T, Agapito MA, Li M, Simonson WTN, Huttenlocher A, Habas R, et al. TRPM7 regulates cell adhesion by controlling the calcium-dependent protease calpain. J Biol Chem 2006; 281:11260-70; PMID:16436382; http://dx.doi.org/10. 1074/jbc.M512885200.
117. Glading A, Chang P, Lauffenburger DA, Wells A. Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem 2000; 275:2390-8; PMID:10644690; http://dx.doi.org/10.1074/jbc.275.4.2390.
118. Su L-T, Chen H-C, González-Pagán O, Overton JD, Xie J, Yue L, et al. TRPM7 activates m-calpain by stress-dependent stimulation of p38 MAPK and c-Jun N-terminal kinase. J Mol Biol 2010; 396:858-69; PMID:20070945; http://dx.doi.org/10.1016/j.jmb.2010.01.014.
119. Su L-T, Liu W, Chen H-C, González-Pagán O, Habas R, Runnels LW. TRPM7 regulates polarized cell movements. Biochem J 2011; 434:513-21; PMID:21208190; http://dx.doi.org/10.1042/BJ20101678.
120. Oancea E, Wolfe JT, Clapham DE. Functional TRPM7 channels accumulate at the plasma membrane in response to fluid flow. Circ Res 2006; 98:245-53; PMID:16357306; http://dx.doi.org/10.1161/01.RES.0000200179.29375.cc.
121. Theriot JA. Accelerating on a treadmill: ADF/cofilin promotes rapid actin filament turnover in the dynamic cytoskeleton. J Cell Biol 1997; 136:1165-8; PMID:9087434; http://dx.doi.org/10.1083/jcb.136.6.1165.
122. Bamburg JR. Proteins of the ADF/cofilin family: essential regulators of actin dynamics. Annu Rev Cell Dev Biol 1999; 15:185-230; PMID:10611961; http://dx.doi.org/10.1146/annurev.cellbio.15.1.185.
123. Maciver SK, Hussey PJ. The ADF/cofilin family: actin-remodeling proteins. Genome Biol 2002; 3:s3007; PMID:12049672; http://dx.doi.org/10.1186/gb-2002-3- 5-reviews3007.
124. Van Troys M, Huyck L, Leyman S, Dhaese S, Vandekerkhove J, Ampe C. Ins and outs of ADF/cofilin activity and regulation. Eur J Cell Biol 2008; 87:649-67; PMID:18499298; http://dx.doi.org/10.1016/j.ejcb.2008.04.001.
125. Arber S, Barbayannis FA, Hanser H, Schneider C, Stanyon CA, Bernard O, et al. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 1998; 393:805-9; PMID:9655397; http://dx.doi.org/10.1038/ 31729.
126. Meng Y, Zhang Y, Tregoubov V, Janus C, Cruz L, Jackson M, et al. Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice. Neuron 2002; 35:121-33; PMID:12123613; http://dx.doi.org/10.1016/S0896-6273(02)00758-4.
127. Meng Y, Zhang Y, Tregoubov V, Falls DL, Jia Z. Regulation of spine morphology and synaptic function by LIMK and the actin cytoskeleton. Rev Neurosci 2003; 14:233-40; PMID:14513866; http://dx.doi.org/10.1515/REVNEURO. 2003.14.3.233.
128. Low SE, Amburgey K, Horstick E, Linsley J, Sprague SM, Cui WW, et al. TRPM7 is required within zebrafish sensory neurons for the activation of touch-evoked escape behaviors. J Neurosci 2011; 31:11633-44; PMID:21832193; http://dx.doi.org/10.1523/JNEUROSCI.4950-10.2011.
129. Jin J, Desai BN, Navarro B, Donovan A, Andrews NC, Clapham DE. Deletion of Trpm7 disrupts embryonic development and thymopoiesis without altering Mg2+ homeostasis. Science 2008; 322:756-60; PMID:18974357; http://dx.doi.org/10.1126/ science.1163493.
130. Jin J, Wu L-J, Jun J, Cheng X, Xu H, Andrews NC, et al. The channel kinase, TRPM7, is required for early embryonic development. Proc Natl Acad Sci USA 2012; 109:E225-33; PMID:22203997; http://dx.doi.org/10.1073/pnas.1120033109.
131. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 79:1431-568; PMID:10508238.
132. Jiang J, Li M, Yue L. Potentiation of TRPM7 inward currents by protons. J Gen Physiol 2005; 126:137-50; PMID:16009728; http://dx.doi.org/10.1085/jgp. 200409185.
133. Kozak JA, Matsushita M, Nairn AC, Cahalan MD. Charge screening by internal pH and polyvalent cations as a mechanism for activation, inhibition, and rundown of TRPM7/MIC channels. J Gen Physiol 2005; 126:499-514; PMID:16260839; http://dx.doi.org/10.1085/jgp.200509324.
134. Li M, Du J, Jiang J, Ratzan W, Su L-T, Runnels LW, et al. Molecular determinants of Mg2+ and Ca2+ permeability and pH sensitivity in TRPM6 and TRPM7. J Biol Chem 2007; 282:25817-30; PMID:17599911; http://dx.doi.org/10.1074/ jbc.M608972200.
135. Shichi K, Fujita-Hamabe W, Harada S, Mizoguchi H, Yamada K, Nabeshima T, et al. Involvement of matrix metalloproteinase-mediated proteolysis of neural cell adhesion molecule in the development of cerebral ischemic neuronal damage. J Pharmacol Exp Ther 2011; 338:701-10; PMID:21602423; http://dx.doi.org/10.1124/ jpet.110.178079.
136. Fujita-Hamabe W, Tokuyama S. The involvement of cleavage of neural cell adhesion molecule in neuronal death under oxidative stress conditions in cultured cortical neurons. Biol Pharm Bull 2012; 35:624-8; PMID:22466571; http://dx.doi.org/10.1248/bpb.35.624.
137. Linder S, Aepfelbacher M. Podosomes: adhesion hotspots of invasive cells. Trends Cell Biol 2003; 13:376-85; PMID:12837608; http://dx.doi.org/10.1016/ S0962-8924(03)00128-4.
138. Proszynski TJ, Gingras J, Valdez G, Krzewski K, Sanes JR. Podosomes are present in a postsynaptic apparatus and participate in its maturation. Proc Natl Acad Sci USA 2009; 106:18373-8; PMID:19822767; http://dx.doi.org/10.1073/pnas. 0910391106.
139. Asrar S, Meng Y, Zhou Z, Todorovski Z, Huang WW, Jia Z. Regulation of hippocampal long-term potentiation by p21-activated protein kinase 1 (PAK1). Neuropharmacology 2009; 56:73-80; PMID:18644395; http://dx.doi.org/10.1016/j. neuropharm.2008.06.055.
140. Zhou Z, Meng Y, Asrar S, Todorovski Z, Jia Z. A critical role of Rho-kinase ROCK2 in the regulation of spine and synaptic function. Neuropharmacology 2009; 56:81-9; PMID:18718479; http://dx.doi.org/10.1016/j. neuropharm.2008.07.031.
141. Langeslag M, Clark K, Moolenaar WH, van Leeuwen FN, Jalink K. Activation of TRPM7 channels by phospholipase C-coupled receptor agonists. J Biol Chem 2007; 282:232-9; PMID:17095511; http://dx.doi.org/10.1074/jbc.M605300200.
142. Chen H-C, Xie J, Zhang Z, Su L-T, Yue L, Runnels LW. Blockade of TRPM7 channel activity and cell death by inhibitors of 5-lipoxygenase. PLoS ONE 2010; 5:e11161; PMID:20567598; http://dx.doi.org/10.1371/journal.pone.0011161.
143. Chubanov V, Mederos Y, Schnitzler M, Meißner M, Schäfer S, Abstiens K, Hofmann T. Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7. British journal of pharmacology [Internet] 2012 [cited 2012 May 14]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/22242975
144. Chen X, Numata T, Li M, Mori Y, Orser BA, Jackson MF, et al. The modulation of TRPM7 currents by nafamostat mesilate depends directly upon extracellular concentrations of divalent cations. Mol Brain 2010; 3:38; PMID:21122141; http://dx.doi.org/10.1186/1756-6606-3-38.
145. Castillo B, Pörzgen P, Penner R, Horgen FD, Fleig A. Development and optimization of a high-throughput bioassay for TRPM7 ion channel inhibitors. J Biomol Screen 2010; 15:498-507; PMID:20413646; http://dx.doi.org/10.1177/ 1087057110368294.